Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1991 1
1992 1
1993 2
1994 2
1996 1
1998 1
1999 1
2001 1
2003 1
2004 1
2007 1
2009 2
2010 1
2014 1
2016 1
2017 3
2018 1
2021 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study.
Phillips T, Brunvand M, Chen AI, Essell J, Chiappella A, Diefenbach C, Cheng J, Ramies D, Hirata J, Morschhauser F, Flinn IW. Phillips T, et al. Among authors: brunvand m. Am J Hematol. 2022 Jan 1;97(1):E24-E27. doi: 10.1002/ajh.26400. Epub 2021 Nov 30. Am J Hematol. 2022. PMID: 34731510 Free article. Clinical Trial. No abstract available.
Chronic recurrent Goodpasture's syndrome.
Mehler PS, Brunvand MW, Hutt MP, Anderson RJ. Mehler PS, et al. Among authors: brunvand mw. Am J Med. 1987 Apr;82(4):833-5. doi: 10.1016/0002-9343(87)90024-6. Am J Med. 1987. PMID: 3565437
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S, David D, Brunvand M, Berryman B, Abhyankar S, Bouvier M, McDonald GB. Hockenbery DM, et al. Among authors: brunvand m. Blood. 2007 May 15;109(10):4557-63. doi: 10.1182/blood-2006-05-021139. Epub 2007 Jan 23. Blood. 2007. PMID: 17244684 Free article. Clinical Trial.
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Giles FJ, Rodriguez R, Weisdorf D, Wingard JR, Martin PJ, Fleming TR, Goldberg SL, Anaissie EJ, Bolwell BJ, Chao NJ, Shea TC, Brunvand MM, Vaughan W, Petersen F, Schubert M, Lazarus HM, Maziarz RT, Silverman M, Beveridge RA, Redman R, Pulliam JG, Devitt-Risse P, Fuchs HJ, Hurd DD. Giles FJ, et al. Among authors: brunvand mm. Leuk Res. 2004 Jun;28(6):559-65. doi: 10.1016/j.leukres.2003.10.021. Leuk Res. 2004. PMID: 15120931 Clinical Trial.
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Giles FJ, Miller CB, Hurd DD, Wingard JR, Fleming TR, Sonis ST, Bradford WZ, Pulliam JG, Anaissie EJ, Beveridge RA, Brunvand MM, Martin PJ; PROMPT-CT Trial Investigators. Giles FJ, et al. Among authors: brunvand mm. Leuk Lymphoma. 2003 Jul;44(7):1165-72. doi: 10.1080/1042819031000079159. Leuk Lymphoma. 2003. PMID: 12916869 Clinical Trial.
22 results